Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Lung Cancer

Alembic Pharma gets tentative nod from USFDA for generic cancer drug

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketing exclusivity. Alembic previously received tentative approval for the 15mg strength. Binimetinib…

The Economic Times

Rural areas lag behind in cancer treatment and prevention – even as rich, urban areas increasingly leave dying from cancer in the rearview

Cancer in the United States experienced a dramatic turnaround in 1991. Prior to that year, cancer deaths had been increasing for decades, peaking at 215 deaths per 100,000 people, meaning about 1 in 4 deaths were attributed to cancer. Then it began to consistently decline, decreasing by 34% between 1991…

The Conversation

Could a Simple Blood Test Stop Lung Cancer Early?

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like science fiction, but researchers believe it could soon become reality. A groundbreaking study has identified a unique set of proteins in the blood that may reveal a person's…

MyLifeXP

From analysis to the latest developments in health,
read the most diverse news in one place.

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

MarketBeat

£20m artificial intelligence tech ‘will speed up cancer diagnosis for millions’ of UK patients

More than four million patients have already received a faster lung cancer diagnosis or all-clear thanks to AI, the government have said

The Independent UK

GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year

The Guardian - UK

GSK to buy US lung cancer drug specialist Nuvalent for £8bn

The acquisition is thought to be GSK’s biggest deal in more than a decade.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Could a Blood Test Predict Cancer Before Symptoms Appear?

Lung cancer is often called the silent killer. By the time symptoms appear, the disease has usually advanced, making treatment more difficult and survival chances lower. For decades, doctors have searched for a way to identify risk before cancer takes hold. Now, scientists may have found one. A groundbreaking study…

MyLifeXP

This blood test may reveal lung cancer risk long before symptoms

A new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India. The test identifies individuals at higher risk. This allows for closer monitoring and potential preventive measures. The findings are significant for India's air pollution challenges. This discovery…

The Economic Times

Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA Path

Black Diamond Therapeutics (NASDAQ:BDTX) is positioning its lead oncology drug candidate, silevertinib, as a potential treatment for non-small cell lung cancer patients with non-classical EGFR mutations, Chief Executive Officer Mark Velleca said during a Jefferies fireside chat following the company

MarketBeat

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

OXFORD, United Kingdom and HOUSTON, June 5, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores Optellum's commitment to empowering health systems and clinical care teams with…

AAP

Barry Manilow Cancer Update: Inside Icon's Traumatic Realisation That He May Never Sing Again

Barry Manilow, 82, shares his uncertainty about regaining his singing voice after lung cancer surgery, despite plans to return to the stage in June and July.

International Business Times UK

Barry Manilow fears his voice may not return after lung cancer surgery

Barry Manilow admits he’s unsure whether his voice will fully recover following lung cancer treatment, even as he prepares to return to the stage this summer.

BANG Premier

Barry Manilow Shares Heartbreaking Health Update as Cancer Recovery Leaves Voice 'Unrecognisable'

Barry Manilow discusses his battle with lung cancer and pneumonia, revealing fears of death and the impact on his voice, while remaining determined to return to the stage.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Newly developed drug helps extend the lives of lung cancer patients in trial

IN FULL

The Independent UK

New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer

Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung cancer

The Independent UK

Barry Manilow reveals pneumonia battle after lung cancer surgery

IN FULL

MarketBeat

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit, with the discussion focused primarily on darovasertib combinations in uveal melanoma and several ear

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Groundbreaking urine test could detect lung cancer years before symptoms appear

IN FULL

The Independent UK

New ‘innovative’ urine test that can detect cancer early could be on NHS within years

Scientists, funded by Cancer Research UK, have now passed another hurdle, bringing the test closer to patient use

The Independent UK

Supermarket lung cancer checks find 10,000 cases in England

The initiative forms part of the NHS Lung Cancer Screening Programme which began in 2019

MarketBeat

Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 Study

Black Diamond Therapeutics (NASDAQ:BDTX) reported updated Phase 2 data for silevertinib in treatment-naive non-small cell lung cancer patients with EGFR Non-Classical Mutations, saying the investigational therapy produced a preliminary median progression-free survival of 15.2 months in the study coh

MarketBeat

Candel Therapeutics Eyes Year-End BLA After Strong Prostate Cancer Data

Candel Therapeutics (NASDAQ:CADL) Chief Executive Officer Dr. Paul Peter Tak said the company remains focused on advancing its viral immunotherapy programs following newly presented prostate cancer data and as it prepares for a planned biologics license application submission by the end of the year.

International Business Times UK

Who Was Patriotic Kenny? TikTok Star and Navy Veteran Dies at 84 Following Lung Cancer Diagnosis

Kenneth 'Kenny' Jary, a US Navy veteran and viral TikTok star known as 'Patriotic Kenny', passed away at 84 after battling cancer. He inspired millions with his positivity and charitable work.

MarketBeat

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and colorectal cancers during a Bank of America biotech conference session. Jonathan Lim, Erasca’s chair

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.